Abiomed Inc. logo

Abiomed Inc. Share Price Today (NASDAQ: ABMD)

Abiomed Inc. share price is $0 & ₹0.00 as on 20 Dec 2022 IST

-381.02

(-100%)

Market is closed - opens 7 PM, 09 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 21 Dec 2022

View live Abiomed Inc. share price in Dollar and Rupees. Guide to invest in Abiomed Inc. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Abiomed Inc., along with analyst recommendations, forecasts, and comprehensive financials.

Abiomed Inc. (ABMD) Key Statistics

in dollars & INR

Previous Close
$381.02
Open
$380.78
Market Capitalization
$17.2B
Today's Volume
$20.4M
Revenue TTM
$1.1B
EBITDA
$274.2M
Earnings Per Share (EPS)
$5.82
PE Ratio
65.47
Dividend Yield
0.0%
Profit Margin
24.84%
Quarterly Earnings Growth YOY
0.87%
Return On Equity TTM
18.24%

How to invest in Abiomed Inc. Stock (ABMD) from India?

It is very easy for Indian residents to invest directly in Abiomed Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Abiomed Inc. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Abiomed Inc. or ABMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Abiomed Inc. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Abiomed Inc. shares which would translate to null fractional shares of Abiomed Inc. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Abiomed Inc., in just a few clicks!

Global Institutional Holdings in Abiomed Inc.

  • Vanguard Group Inc

    11.69%

  • BlackRock Inc

    10.11%

  • Baillie Gifford & Co Limited.

    8.04%

  • State Street Corporation

    4.59%

  • PRIMECAP Management Company

    3.34%

  • Wellington Management Company LLP

    3.22%

Analyst Recommendation on Abiomed Inc.

Rating
Trend

Hold

    37%Buy

    62%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Abiomed Inc.(by analysts ranked 0 to 5 stars)

About Abiomed Inc.

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Organization
Abiomed Inc.
Employees
2003
CEO
Mr. Michael R. Minogue
Industry
Health Technology

Important FAQs about investing in ABMD Stock from India :

Can Indians buy Abiomed Inc. shares?

Yes, Indians can invest in the Abiomed Inc. (ABMD) from India.

With INDmoney, you can buy Abiomed Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Abiomed Inc. at zero transaction cost.

How can I buy Abiomed Inc. shares from India?

It is very easy to buy Abiomed Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Abiomed Inc. (ABMD) be purchased?

Yes, you can buy fractional shares of Abiomed Inc. with INDmoney app.

What are the documents required to start investing in Abiomed Inc. stocks?

To start investing in Abiomed Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Abiomed Inc.?

Today's market capitalisation of Abiomed Inc. ABMD is 17.2B

Who is the Chief Executive Officer (CEO) of Abiomed Inc. ?

Mr. Michael R. Minogue is the current Chief Executive Officer (CEO) of Abiomed Inc..